ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
3582 | ||
(State or other jurisdiction of incorporation or organization) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification Number) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Large accelerated filer | o | Accelerated filer | o | |
x | Smaller reporting company | |||
Emerging growth company |
Page | ||






Country | Facilities | Approx. Sq. Ft. | ||
United States | 3 | 2,000,000 | ||
Czech Republic | 1 | 380,000 | ||
Thailand | 1 | 280,000 | ||
China | 1 | 60,000 |
Country | ISO Certification | |
United States | 9001 | |
Czech Republic | 9001 14001 45001 50001 | |
Thailand | 9001 14001 45001 50001 | |
China | 9001 14001 45001 |
No. of Facilities | ||||||||
Locations | Manufacturing | Distribution / Sales Offices with Warehouses | Sales / Corporate Offices Only | Warehouses | ||||
United States | ||||||||
Wisconsin | 3 | 1 | 2 | |||||
Florida | 1 | |||||||
Texas | 2 | |||||||
California | 4 | 2 | ||||||
New York | 2 | |||||||
Georgia | 1 | |||||||
Illinois | 1 | 1 | ||||||
Washington | 1 | |||||||
Oregon | 1 | |||||||
Maryland | 1 | 1 | ||||||
Pennsylvania | 1 | |||||||
Utah | 1 | |||||||
Tennessee | 1 | |||||||
Rest of World | ||||||||
China | 1 | 1 | 1 | |||||
Czech Republic | 1 | 1 | ||||||
Thailand | 1 | 1 | ||||||
Brazil | 1 | 2 | ||||||
France | 1 | 1 | ||||||
Germany | 1 | |||||||
Italy | 1 | 1 | ||||||
Netherlands | 1 | |||||||
Spain | 1 | 1 | ||||||
UAE | 1 | |||||||
Belgium | 1 | |||||||

For the Year Ended December 31, | |||||
(in thousands except for percentages) | 2025 | 2024 | 2023 | ||
Net income | $101,755 | $98,319 | $88,229 | ||
Provision for income taxes | 36,279 | 25,130 | 16,226 | ||
Interest expense | 150,501 | 132,001 | 123,397 | ||
Depreciation and amortization | 93,701 | 90,169 | 88,704 | ||
EBITDA | 382,236 | 345,619 | 316,556 | ||
Refinancing and debt related costs (1) | 3,679 | 33,217 | — | ||
Share-based compensation (2) | 19,779 | 3,263 | 3,343 | ||
Pension termination costs (3) | — | — | 7,011 | ||
Strategic transaction costs (4) | 5,627 | 5,803 | 1,083 | ||
Foreign exchange losses/(gains) on intercompany loans (5) | 25,152 | (4,654) | 484 | ||
Adjusted EBITDA | 436,473 | 383,248 | 328,477 | ||
Net revenues | $1,709,237 | $1,508,440 | $1,365,154 | ||
Net income margin | 6.0% | 6.5% | 6.5% | ||
Adjusted EBITDA Margin | 25.5% | 25.4% | 24.1% | ||
(in thousands) | December 31, 2025 | December 31, 2024 | |
Net revenues: | |||
Equipment, service parts and other | $1,659,680 | $1,459,746 | |
Equipment financing | 49,557 | 48,694 | |
Net revenues | 1,709,237 | 1,508,440 | |
Costs and expenses: | |||
Cost of sales | 1,028,073 | 914,655 | |
Cost of sales - related parties | 7,322 | 6,218 | |
Equipment financing expenses | 31,738 | 36,316 | |
Gross profit | 642,104 | 551,251 | |
Selling, general, and administrative expenses | 324,458 | 266,444 | |
Selling, general, and administrative expenses - related parties | 280 | 300 | |
Other costs | — | 494 | |
Total operating expenses | 324,738 | 267,238 | |
Operating income | 317,366 | 284,013 | |
Interest expense, net | 150,501 | 132,001 | |
Other expenses, net | 28,831 | 23,376 | |
Other expenses, net - related parties | — | 5,187 | |
Income before taxes | 138,034 | 123,449 | |
Provision for income taxes | 36,279 | 25,130 | |
Net income | $101,755 | $98,319 |
Year Ended December 31, | |||||
(in thousands, except for percentages) | 2025 | 2024 | 2023 | ||
North America | |||||
Net revenues | $1,268,979 | $1,109,134 | $996,762 | ||
Adjusted EBITDA | $361,487 | $317,779 | $265,391 | ||
Adjusted EBITDA Margin | 28.5% | 28.7% | 26.6% | ||
International | |||||
Net revenues | $440,258 | $399,306 | $368,392 | ||
Adjusted EBITDA | $120,597 | $103,148 | $94,402 | ||
Adjusted EBITDA Margin | 27.4% | 25.8% | 25.6% | ||
Year Ended December 31, | ||||
(in thousands) | 2025 | 2024 | ||
Net cash provided by operating activities | $211,685 | $145,460 | ||
Net cash used in investing activities | (91,647) | (87,760) | ||
Net cash used in financing activities | (157,910) | (75,374) | ||
Effect of exchange rate changes on cash and cash | (467) | (4,253) | ||
Increase/(decrease) in cash, cash equivalents, and restricted cash | $(38,339) | $(21,927) | ||
Page | ||
Product Warranty Liability | ||
Description of the Matter | At December 31, 2025, the Company’s product warranty liability was $69.2 million. As more fully described in Notes 2 and 16 to the consolidated financial statements, the Company estimates and records provisions for future product warranty liability claims at the time of sale based on projected incident rates of occurrence and projected cost per incident. The Company estimates its product warranty liability based on the specific product type, product use, and warranty period, which generally ranges from one to seven years. Auditing the Company’s product warranty liability was complex due to the judgmental nature of management’s assumptions used to estimate the future commercial in-home product warranty liability for standard product warranty periods extending beyond three years, including the projected incident rates of occurrence and the projected cost per incident. In particular, there is a higher level of estimation uncertainty in determining the future projected incident rates of occurrence, which may not be reflective of historical incident rates or may not reflect product quality issues that have not yet been identified as of the financial statement date. Additionally, the projected cost per incident reflects management’s estimates of the future cost of replacement product parts, the cost of labor, and the amount of labor required to address the product warranty claim and changes in these estimates could have a material effect on the amount of product warranty liability recognized. | |
How We Addressed the Matter in Our Audit | To test the adequacy of the Company’s calculation of the product warranty liability, our substantive audit procedures included, among others, testing the accuracy and completeness of the underlying data used in the product warranty liability calculation and significant assumptions discussed above. We tested the categorization of claims within the product warranty liability calculation and tested the completeness and accuracy of the claims settled data. We compared the historical incident rates of occurrence by product type, using actual claims data, to the projected incident rates of occurrence. We also compared the projected cost per incident to the average cost per incident using actual claims data. We assessed the historical accuracy of management's estimates by comparing the product warranty liability in the prior year to the actual claims paid in the subsequent year. | |
December 31, 2025 | December 31, 2024 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents | $ | $ | |
Restricted cash | |||
Restricted cash - for securitization investors | |||
Accounts receivable (net of allowance for credit losses of $ | |||
Inventories, net | |||
Inventories, net - related parties | |||
Accounts receivable, net - restricted for securitization investors | |||
Equipment financing receivables, net | |||
Equipment financing receivables, net - restricted for securitization investors | |||
Prepaid expenses and other current assets | |||
Total current assets | |||
Equipment financing receivables, net | |||
Property, plant, and equipment, net | |||
Operating lease right-of-use assets | |||
Equipment financing receivables, net - restricted for securitization investors | |||
Deferred income tax asset | |||
Debt issuance costs, net | |||
Goodwill | |||
Intangible assets, net | |||
Other long-term assets | |||
Total assets | $ | $ | |
Liabilities and Stockholders' Equity/(Deficit) | |||
Current liabilities: | |||
Current portion of long-term debt | $ | $ | |
Accounts payable | |||
Accounts payable - related parties | |||
Asset backed borrowings - owed to securitization investors | |||
Current operating lease liabilities | |||
Other current liabilities | |||
Total current liabilities | |||
Long-term debt, net | |||
Asset backed borrowings - owed to securitization investors | |||
Deferred income tax liability | |||
Long-term operating lease liabilities | |||
Other long-term liabilities | |||
Total liabilities | |||
Commitments and contingencies (see Note 24) | |||
Stockholders' equity/(deficit): | |||
Redeemable preferred stock, $ | |||
Common stock, $ | |||
Additional paid-in capital | |||
(Accumulated deficit)/retained earnings | ( | ||
Accumulated other comprehensive income/(loss) | ( | ||
Treasury stock, at cost, | ( | ||
Total stockholders' equity/(deficit) | ( | ||
Total liabilities and stockholders' equity/(deficit) | $ | $ |
December 31, 2025 | December 31, 2024 | December 31, 2023 | |||
Net revenues: | |||||
Equipment, service parts and other | $ | $ | $ | ||
Equipment financing | |||||
Net revenues | |||||
Costs and expenses: | |||||
Cost of sales | |||||
Cost of sales - related parties | |||||
Equipment financing expenses | |||||
Gross profit | |||||
Selling, general, and administrative expenses | |||||
Selling, general, and administrative expenses - related parties | |||||
Other costs | |||||
Total operating expenses | |||||
Operating income | |||||
Interest expense, net | |||||
Other expenses, net | |||||
Other expenses, net - related parties | |||||
Income before taxes | |||||
Provision for income taxes | |||||
Net income | $ | $ | $ | ||
Comprehensive income: | |||||
Net income | $ | $ | $ | ||
Other comprehensive income/(loss): | |||||
Foreign currency translation adjustment | ( | ||||
Change in pension liability and other post-retirement benefits, net of taxes of $ ($ | ( | ||||
Total other comprehensive income/(loss) | ( | ||||
Comprehensive income | $ | $ | $ | ||
Net income per share attributable to common stockholders: | |||||
Basic | $ | $ | $ | ||
Diluted | $ | $ | $ | ||
Weighted average number of common shares outstanding | |||||
Basic | |||||
Diluted | |||||
Dividends declared per share of common stock | $ | $ | $ |
Common Stock | Paid-in Capital | Treasury Stock | (Accumulate d Deficit)/ Retained Earnings | Accumulated Other Comprehensive Income/(loss) | Total Stockholders' Equity/(Deficit) | ||||||
Balances at December 31, 2022 | $ | $ | $( | $ | $ | $ | |||||
Net income | — | — | — | — | |||||||
Foreign currency translation adjustment | — | — | — | — | |||||||
Change in pension liability and other post-retirement benefits, net | — | — | — | — | |||||||
Exercise of stock options and taxes paid for net share settlement | ( | — | — | — | ( | ||||||
Exercise of stock options | — | — | — | — | |||||||
Repurchase of common stock | — | — | ( | — | — | ( | |||||
Share-based compensation | — | — | — | — | |||||||
Balances at December 31, 2023 | ( | ||||||||||
Net income | — | — | — | — | |||||||
Foreign currency translation adjustment | — | — | — | — | ( | ( | |||||
Change in pension liability and other post-retirement benefits, net | — | — | — | — | |||||||
Exercise of stock options and taxes paid for net share settlement | ( | — | — | — | ( | ||||||
Exercise of stock options | — | — | — | — | |||||||
Repurchase of common stock | — | — | ( | — | — | ( | |||||
Dividends | — | — | — | ( | — | ( | |||||
Return of capital | — | ( | — | — | — | ( | |||||
Share-based compensation | — | — | — | — | |||||||
Balances at December 31, 2024 | ( | ( | ( | ||||||||
Net income | — | — | — | — | |||||||
Foreign currency translation adjustment | — | — | — | — | |||||||
Change in other post-retirement benefits, net | — | — | — | — | ( | ( | |||||
Exercise of stock options and taxes paid for net share settlement | ( | — | ( | — | ( | ||||||
Exercise of stock options | — | — | — | ||||||||
Exercise of warrants | ( | — | — | — | |||||||
Issuance of common stock | — | — | — | — | |||||||
Common stock issued pursuant to initial public offering, net of offering costs | — | — | — | ||||||||
Repurchase of common stock | — | — | ( | — | — | ( | |||||
Share-based compensation | — | — | — | — | |||||||
Retirement of treasury stock | ( | ( | ( | — | |||||||
Balances at December 31, 2025 | $ | $ | $ | $( | $ | $ |
December 31, 2025 | December 31, 2024 | December 31, 2023 | |||
Cash flows from operating activities: | |||||
Net income | $ | $ | $ | ||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||
Depreciation and amortization | |||||
Amortization and extinguishment of debt issuance costs | |||||
Amortization of original issue discount | |||||
Non-cash interest expense/(income) | ( | ||||
Non-cash (gain)/loss on commodity & foreign exchange contracts, net | ( | ||||
Non-cash foreign exchange loss/(gain), net | ( | ||||
Non-cash stock-based compensation | |||||
Non-cash (gain)/loss for pension and post-retirement benefit plans | ( | ||||
Loss on sale of property, plant, and equipment | |||||
Provision for credit losses | |||||
Deferred income taxes | ( | ( | ( | ||
Other, net | ( | ||||
Changes in assets and liabilities, net of the effects of acquisitions: | |||||
Accounts and equipment financing receivables, net | ( | ||||
Accounts receivable - restricted for securitization investors | ( | ||||
Inventories, net | ( | ||||
Inventories, net - related party | ( | ||||
Equipment financing receivables, net - restricted for securitization investors | ( | ( | ( | ||
Other assets | |||||
Accounts payable | ( | ( | |||
Accounts payable - related parties | ( | ||||
Other liabilities | ( | ||||
Net cash provided by operating activities | |||||
Cash flows from investing activities: | |||||
Capital expenditures | ( | ( | ( | ||
Acquisition of businesses, net of cash acquired | ( | ( | ( | ||
Proceeds on disposition of assets | |||||
Originations of equipment financing receivables, net - restricted for securitization investors | ( | ( | ( | ||
Collections of equipment financing receivables, net - restricted for securitization investors | |||||
Net cash used in investing activities | ( | ( | ( | ||
Cash flows from financing activities: | |||||
Payments on revolving line of credit borrowings | ( | ( | |||
Proceeds from long-term borrowings | |||||
Payments on long-term borrowings | ( | ( | ( | ||
Cash paid for debt establishment and amendment fees | ( | ( | |||
Proceeds from initial public offering, net of issuance costs | |||||
Increase in asset backed borrowings owed to securitization investors | |||||
Decrease in asset backed borrowings owed to securitization investors | ( | ( | ( | ||
Dividends paid | ( | ||||
Return of capital paid | ( | ||||
Repurchase of common stock | ( | ( | ( | ||
Taxes paid related to net share settlement of stock options | ( | ( | ( | ||
Net proceeds from stock options exercised | |||||
Proceeds from common stock issuance under employee purchase plan | |||||
Net cash used in financing activities | ( | ( | ( | ||
Effect of exchange rate changes on cash, cash equivalents, and restricted cash | ( | ( | ( | ||
(Decrease)/increase in cash, cash equivalents, and restricted cash | ( | ( | |||
Cash, cash equivalents, and restricted cash at beginning of period | |||||
Cash, cash equivalents, and restricted cash at end of period | $ | $ | $ | ||
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets: | |||||
Cash and cash equivalents | $ | $ | $ | ||
Restricted cash | |||||
Restricted cash - for securitization investors | |||||
Total cash, cash equivalents, and restricted cash shown in the Statement of Cash Flows | $ | $ | $ | ||
Supplemental disclosure of cash flow information: | |||||
Cash paid for interest | $ | $ | $ | ||
Cash paid for interest - to securitized investors | $ | $ | $ | ||
Cash paid for income taxes | $ | $ | $ | ||
Supplemental disclosure of investing and financing non-cash activities: | |||||
Capital expenditures included in accounts payable | $ | $ | $ |
Year Ended December 31, | |||||
(in thousands) | 2025 | 2024 | 2023 | ||
North America | |||||
Equipment | $ | $ | $ | ||
Service parts | |||||
Equipment financing | |||||
Other | |||||
Total North America Net revenues | |||||
International | |||||
Equipment | |||||
Service parts | |||||
Equipment financing | |||||
Other | |||||
Total International Net revenues | |||||
Total Net revenues | $ | $ | $ | ||
Year Ended December 31, | |||||
(in thousands) | 2025 | 2024 | 2023 | ||
Total purchase price | $ | $ | $ | ||
Allocation of purchase price: | |||||
Assets acquired: | |||||
Accounts receivables | |||||
Inventories, net | |||||
Property, plant, and equipment, net | |||||
Intangible assets - customer relationships | |||||
Total assets acquired | $ | $ | $ | ||
Total liabilities assumed | |||||
Total net assets acquired | $ | $ | $ | ||
Goodwill | |||||
Total purchase price allocation | $ | $ | $ | ||
Year Ended December 31, | |||||
(in thousands) | 2025 | 2024 | 2023 | ||
Foreign exchange losses/(gains) on intercompany loans | $ | $( | $ | ||
Debt issuance cost write-offs and amendment expenses | |||||
Non-service components of net periodic pension expense | |||||
Pension settlement loss | |||||
Other expenses, net | $ | $ | $ | ||
(in thousands) | December 31, 2025 | December 31, 2024 | |
Cash reserve accounts | $ | $ | |
Collection accounts - accounts receivable | |||
Collection accounts - equipment financing receivables | |||
Restricted cash - for securitization investors | $ | $ |
(in thousands) | December 31, 2025 | December 31, 2024 | |
Accounts receivable - restricted for securitization investors | $ | $ | |
Less: Allowance for accounts receivable credit losses | ( | ( | |
Accounts receivable, net - restricted for securitization investors | |||
Less: Asset backed borrowings - owed to securitization investors | ( | ( | |
Company's residual interest in securitized accounts receivable | $ | $ |
December 31, 2025 | December 31, 2024 | ||||||
(in thousands) | Current | Long-term | Current | Long-term | |||
Equipment financing receivables - restricted for securitization investors | $ | $ | $ | $ | |||
Less: Allowance for equipment financing receivables credit losses | ( | ( | ( | ( | |||
Equipment financing receivables, net - restricted for securitization investors | |||||||
Less: Asset backed borrowings - owed to securitization investors | ( | ( | ( | ( | |||
Company's residual interest in securitized equipment financing receivables | $ | $ | $ | $ | |||
Year | Related to Trade Receivables | Related to Equipment Financing Receivables | Total Securitization Debt | ||
2026 | $ | $ | $ | ||
2027 | |||||
2028 | |||||
2029 | |||||
2030 | |||||
Thereafter | |||||
Securitization Debt | $ | $ | $ |
December 31, 2025 | 2025 | 2024 | 2023 | 2022 | 2021 | Prior | Total | |||||||
Securitized | ||||||||||||||
Current | $ | $ | $ | $ | $ | $ | $ | |||||||
30-59 Days | ||||||||||||||
60-89 Days | ||||||||||||||
Total past due accruing | ||||||||||||||
Over 89 Days non-performing | ||||||||||||||
Total Securitized | $ | $ | $ | $ | $ | $ | $ | |||||||
Current period gross charge-offs | $ | $ | $ | $ | $ | $ | $ | |||||||
Unsecuritized | ||||||||||||||
Current | $ | $ | $ | $ | $ | $ | $ | |||||||
30-59 Days | ||||||||||||||
60-89 Days | ||||||||||||||
Total past due accruing | ||||||||||||||
Over 89 Days non-performing | ||||||||||||||
Total Unsecuritized | $ | $ | $ | $ | $ | $ | $ | |||||||
Current period gross charge-offs | $ | $ | $ | $ | $ | $ | $ |
December 31, 2024 | 2024 | 2023 | 2022 | 2021 | 2020 | Prior | Total | |||||||
Securitized | ||||||||||||||
Current | $ | $ | $ | $ | $ | $ | $ | |||||||
30-59 Days | ||||||||||||||
60-89 Days | ||||||||||||||
Total past due accruing | ||||||||||||||
Over 89 Days non-performing | ||||||||||||||
Total Securitized | $ | $ | $ | $ | $ | $ | $ | |||||||
Current period gross charge-offs | $ | $ | $ | $ | $ | $ | $ | |||||||
Unsecuritized | ||||||||||||||
Current | $ | $ | $ | $ | $ | $ | $ | |||||||
30-59 Days | ||||||||||||||
60-89 Days | ||||||||||||||
Total past due accruing | ||||||||||||||
Over 89 Days non-performing | ||||||||||||||
Total Unsecuritized | $ | $ | $ | $ | $ | $ | $ | |||||||
Current period gross charge-offs | $ | $ | $ | $ | $ | $ | $ |
(in thousands) | Balance at Beginning of Period | Current Period Provision | Actual Write-Off’s | Recoveries | Impact of Foreign Exchange Rates | Balance at End of Period | |||||
Unsecuritized Equipment Financing Receivables Portfolio | |||||||||||
Period ended: | |||||||||||
December 31, 2025 | $ | ( | $ | ||||||||
December 31, 2024 | $ | ( | ( | $ | |||||||
December 31, 2023 | $ | ( | $ | ||||||||
Securitized Equipment Financing Receivables Portfolio - restricted for securitization investors | |||||||||||
Period ended: | |||||||||||
December 31, 2025 | $ | ( | $ | ||||||||
December 31, 2024 | $ | ( | $ | ||||||||
December 31, 2023 | $ | ( | $ |
Year Ended December 31, | |||||
(in thousands) | 2025 | 2024 | 2023 | ||
Amortization expense and extinguishment of debt issuance costs | $ | $ | $ | ||
(in thousands) | 2025 | 2024 | |
Finished goods | $ | $ | |
Raw materials | |||
Work in process | |||
Inventories, net | $ | $ |
(in thousands) | 2025 | 2024 | ||
Land | $ | $ | ||
Buildings and leasehold improvements | ||||
Finance leases | ||||
Machinery and equipment | ||||
Less: accumulated depreciation | ( | ( | ||
Construction in progress | ||||
Total Property, plant and equipment, net | $ | $ |
(in thousands) | December 31, 2025 | December 31, 2024 | December 31, 2023 | ||
Operating lease expense | $ | $ | $ | ||
Variable lease expense | |||||
Short-term lease expense | |||||
Total Operating lease expense | $ | $ | $ |
(in thousands) | December 31, 2025 | December 31, 2024 | |
Operating Leases | |||
Operating lease right-of-use assets | $ | $ | |
Current liabilities | $ | $ | |
Long-term liabilities | $ | $ | |
Weighted average remaining lease term | |||
Operating leases | |||
Weighted Average discount rates | |||
Operating leases |
(in thousands) | December 31, 2025 | December 31, 2024 | December 31, 2023 | ||
Cash paid for amounts included in the measurement of Operating lease liabilities | $ | $ | $ | ||
Operating lease ROU assets obtained in the exchange for Operating lease liabilities | $ | $ | $ |
(in thousands) | December 31, 2025 |
Amounts Due In | |
2026 | $ |
2027 | |
2028 | |
2029 | |
2030 | |
Thereafter | |
Total lease payments | |
Less: Imputed interest | ( |
Total | $ |
(in thousands) | Gross Amount | Accumulated Amortization | Net Amount | Weighted Average Life Remaining | |||
Identifiable intangible assets: | |||||||
Trademarks and tradenames, indefinite lives | $ | $— | $ | Indefinite | |||
Trademarks and tradenames, definite lives | |||||||
Customer agreements and distributor network | |||||||
Engineering and manufacturing designs and processes | |||||||
Patents | |||||||
Computer software and other | |||||||
$ | $ | $ |
(in thousands) | Gross Amount | Accumulated Amortization | Net Amount | Weighted Average Life Remaining | |||
Identifiable intangible assets: | |||||||
Trademarks and tradenames, indefinite lives | $ | $— | $ | Indefinite | |||
Trademarks and tradenames, definite lives | |||||||
Customer agreements and distributor network | |||||||
Engineering and manufacturing designs and processes | |||||||
Patents | |||||||
Computer software and other | |||||||
$ | $ | $ |
Year Ended December 31, | |||||
(in thousands) | 2025 | 2024 | 2023 | ||
Amortization expense | $ | $ | $ | ||
(in thousands) | North America | Europe | Asia | Middle East & Africa | Consolidated | ||||
Balance, December 31, 2023⁽¹⁾ | $ | $ | $ | $ | $ | ||||
Goodwill acquired | |||||||||
Measurement period adjustments | ( | ( | |||||||
Currency translation | ( | ( | ( | ( | |||||
Balance, December 31, 2024⁽¹⁾ | $ | $ | $ | $ | $ | ||||
Goodwill acquired | |||||||||
Measurement period adjustments | ( | ( | |||||||
Currency translation | |||||||||
Balance, December 31, 2025⁽¹⁾ | $ | $ | $ | $ | $ |
December 31, 2025 Fair Value (Level 2) | Location on Balance Sheet | Term | ||||||||
(in thousands) | Notional Amount | Liabilities | ||||||||
Undesignated derivatives: | ||||||||||
Interest rate swap | $ | $ | $ | Other current liabilities and long-term liabilities | Various through 4/3/2028 | |||||
Commodity hedges | Prepaid expenses and other current assets and Other current liabilities | Various through 1/5/27 | ||||||||
Interest rate cap | Other long-term assets | Various through 9/15/31 | ||||||||
Total undesignated derivatives | $ | $ | ||||||||
December 31, 2024 Fair Value (Level 2) | Term | |||||||||
(in thousands) | Notional Amount | Assets | Location on Balance Sheet | |||||||
Undesignated derivatives: | ||||||||||
Interest rate swap | $ | $ | $ | Prepaid expenses and other current assets and Other assets | Through 9/1/27 | |||||
Commodity hedges | Other current liabilities | Various through 12/31/25 | ||||||||
Interest rate cap | Other long-term assets | Various through 9/15/31 | ||||||||
Total undesignated derivatives | $ | $ | ||||||||
Gain/(Loss) Recognized on Undesignated Derivatives | ||||||||
(in thousands) | Location in Consolidated Statements of Comprehensive Income | Year Ended December 31, | ||||||
Undesignated Derivatives | 2025 | 2024 | 2023 | |||||
Interest rate swap | Interest expense, net | $( | $ | $ | ||||
Foreign currency hedges | Cost of sales | ( | ||||||
Commodity hedges | Cost of sales | ( | ( | |||||
Interest rate cap | Interest expense, net | ( | ||||||
$( | $ | $ | ||||||
(in thousands) | December 31, 2025 | December 31, 2024 | |
Salaries, wages and other employee benefits | $ | $ | |
Product warranties | |||
Accrued interest | |||
Accrued sales incentives | |||
Income taxes | |||
Other current liabilities | |||
$ | $ |
Year Ended December 31, | |||||
(in thousands) | 2025 | 2024 | 2023 | ||
Domestic | $ | $ | $ | ||
Foreign | |||||
$ | $ | $ | |||
(in thousands) | December 31, 2025 | December 31, 2024 | December 31, 2023 | ||
Current: | |||||
Federal | $ | $ | $ | ||
State | |||||
Foreign | |||||
Total current | |||||
Deferred: | |||||
Federal | ( | ( | ( | ||
State | ( | ( | ( | ||
Foreign | ( | ( | ( | ||
Total deferred | ( | ( | ( | ||
Provision for income taxes | $ | $ | $ |
(In thousands) | Year Ended December 31, 2025 |
U.S. federal | $ |
State: | |
Other | |
State subtotal | |
Foreign: | |
Czech Republic | |
Other | |
Foreign subtotal | |
Total income taxes paid | $ |
(In thousands) | Year Ended December 31, 2025 | ||
US Federal Statutory Income Tax Rate | $ | ||
Domestic State and Local Income Taxes, net of federal effect* | |||
Domestic Federal | |||
Tax Credits | |||
Foreign Tax Credit | ( | ( | |
Other | ( | ( | |
Changes in valuation allowance - Foreign Tax Credit | |||
Nontaxable and Nondeductible Items | |||
Excess tax benefits of stock-based payments | ( | ( | |
Officers compensation limitation - IRC Section 162(m) | |||
Other | |||
Cross-Border Tax Laws | |||
Other | |||
Other | |||
Foreign Tax Effects | |||
Brazil | |||
Czech Republic | |||
Luxembourg | |||
Changes in valuation allowance | ( | ( | |
Changes in net operating losses | |||
Other | |||
Thailand | |||
Statutory income tax rate differential | ( | ( | |
Other | |||
Other Foreign Jurisdictions | ( | ( | |
Worldwide Changes in Unrecognized Tax Benefits | |||
Effective Tax Rate | $ | ||

December 31, 2024 | December 31, 2023 | |||
Statutory U.S. federal tax rate | ||||
State taxes, net of federal benefit | ||||
Foreign rate differential | ( | ( | ||
Change in unrecognized tax benefit | ||||
Valuation allowance | ( | ( | ||
Rate change | ( | ( | ||
Foreign tax credit | ( | ( | ||
U.S. tax on foreign earnings | ||||
Provision to Return | ( | |||
Research and development tax credit | ( | ( | ||
Stock-based compensation | ( | ( | ||
Foreign-derived intangible income deduction | ( | ( | ||
BEPS Pillar Two tax | ||||
Other, net | ( | |||
Effective income tax rate |
(in thousands) | December 31, 2025 | December 31, 2024 | |
Deferred income tax liabilities: | |||
Goodwill | $( | $( | |
Intangible assets | ( | ( | |
Property, plant and equipment | ( | ( | |
Deferred financing costs | ( | ||
Unremitted Foreign Earnings | ( | ||
Other | ( | ( | |
Deferred income tax liabilities | ( | ( | |
Deferred income tax assets: | |||
Inventory | |||
Debt issuance costs | |||
Product warranties | |||
Net operating loss and credit carry forwards | |||
Other assets | |||
Pensions and employee benefits | |||
Interest limitation | |||
Research and development costs | |||
Unrealized Foreign Exchange Gain/Loss | |||
Other | |||
Gross deferred income tax assets | |||
Less: valuation allowance | ( | ( | |
Deferred income tax assets | |||
Net deferred income tax liability | $( | $( |
Year Ended December 31, | |||||
(in thousands) | 2025 | 2024 | 2023 | ||
Beginning balance | $ | $ | $ | ||
Additions based on tax positions related to the current year | |||||
Subtractions based on lapse of statute | ( | ( | ( | ||
(Subtractions)/additions based on tax positions related to the prior year | ( | ||||
Ending balance | $ | $ | $ | ||
Year Ended December 31, | |||||
(in thousands, except per share amounts) | 2025 | 2024 | 2023 | ||
Tax benefit related to tax holidays | $ | $ | $ | ||
Impact of tax holiday on basic net income per share | $ | $ | $ | ||
Impact of tax holiday on diluted net income per share | $ | $ | $ | ||
Year Ended December 31, | |||
(in thousands) | 2025 | 2024 | |
Balance at beginning of period | $ | $ | |
Currency translation adjustment | ( | ||
Accruals charged to earnings | |||
Payments made during the period | ( | ( | |
Balance at end of period | $ | $ | |
(in thousands) | Year Ended December 31, 2023 |
Service cost benefits earned during the period | $ |
Interest cost on projected benefit obligation | |
Expected return on plan assets | ( |
Amortization of net actuarial losses | |
Settlement loss | |
Net pension loss | $ |
Year Ended December 31, 2023 | |
Discount rate | |
Expected long-term rate of return on assets |
(in thousands) | 2023 |
Change in benefit obligation: | |
Benefit obligation at beginning of period | $ |
Service cost | |
Interest cost | |
Actuarial loss | |
Benefits paid | ( |
Plan termination settlements | ( |
Benefit obligation at end of period | $ |
Change in plan assets: | |
Fair value of plan assets at beginning of period | $ |
Actual return on plan assets | ( |
Employer contributions | |
Benefits paid | ( |
Plan termination settlements | ( |
Fair value of plan assets at end of period | $ |
Funded status (liability) | $ |
Year Ended December 31, | |||||
(in thousands) | 2025 | 2024 | 2023 | ||
Service cost benefits earned during the period | $ | $ | $ | ||
Interest cost on projected benefit obligation | |||||
Amortization of prior service (credit) | ( | ( | ( | ||
Amortization of net actuarial (gain) | ( | ( | ( | ||
Net other post-retirement benefit cost | $ | $ | $ | ||
2025 | 2024 | ||
Change in benefit obligation: | |||
Benefit obligation at beginning of period | $ | $ | |
Service cost | |||
Interest cost | |||
Actuarial gain | ( | ||
Benefits paid | ( | ( | |
Benefit obligation at end of period | $ | $ | |
Change in plan assets: | |||
Contributions | $ | $ | |
Benefits paid | ( | ( | |
Fair value of plan assets at end of year | $ | $ | |
Funded status (liability) | $( | $( | |
Amounts recognized in Consolidated Balance Sheets: | |||
Other current liabilities | $( | $( | |
Other long-term liabilities | ( | ( | |
$( | $( |
Year | Other Benefits |
2026 | $ |
2027 | |
2028 | |
2029 | |
2030 | |
2031 and thereafter |
Other Benefits | |
Balances at December 31, 2023 | $ |
Net gain | |
Amortization of net gain | ( |
Other recognition of prior service (credit) | ( |
Deferred tax | ( |
Balances at December 31, 2024 | |
Net (loss) | ( |
Amortization of net gain | ( |
Other recognition of prior service (credit) | ( |
Deferred tax | |
Balances at December 31, 2025 | $ |
(in thousands) | December 31, 2025 | December 31, 2024 | |
Term Loan due August 2031 ( respectively) | $ | $ | |
Finance lease obligations | |||
Gross long-term debt | |||
Less: current portion of Term Loan | ( | ||
Less: current portion of finance lease obligations | ( | ( | |
Less: unamortized debt issuance costs on Term Loan | ( | ( | |
Less: unamortized original issue discount on Term Loan | ( | ( | |
Long-term debt, net | $ | $ |
Year Ended December 31, | |||||
(dollars in thousands) | 2025 | 2024 | 2023 | ||
Amortization expense - debt issuance costs | $ | $ | $ | ||
Amortization expense - original issue discount | $ | $ | $ | ||
Year | Amount Due |
2026 | $ |
2027 | |
2028 | |
2029 | |
2030 | |
Thereafter | |
Less: Current portion | ( |
Less: unamortized debt issuance costs on Term Loan | ( |
Less: unamortized original issue discount on Term Loan | ( |
Long-term debt | $ |
Pension Liability, and Other Post- retirement Benefits, Net | Foreign Currency Translation | Total | |||
Balance as of December 31, 2022 | $( | $ | $ | ||
Other comprehensive income/(loss) before reclassifications | |||||
Amounts reclassified from accumulated other comprehensive income/(loss) | |||||
Net other comprehensive income | |||||
Balance as of December 31, 2023 | |||||
Other comprehensive income/(loss) before reclassifications | ( | ( | |||
Amounts reclassified from accumulated other comprehensive income/(loss) | ( | ( | |||
Net other comprehensive income/(loss) | ( | ( | |||
Balance as of December 31, 2024 | ( | ( | |||
Other comprehensive income/(loss) before reclassifications | ( | ||||
Amounts reclassified from accumulated other comprehensive income/(loss) | ( | ( | |||
Net other comprehensive (loss)/income | ( | ||||
Balance as of December 31, 2025 | $ | $ | $ |
Gain/(loss) Reclassified | |||||
Year Ended December 31, | |||||
(in thousands) | 2025 | 2024 | 2023 | ||
Pension and post-retirement benefits, pre-tax: | |||||
Amortization of prior service credit(1) | $( | $( | $( | ||
Amortization of actuarial gain(1) | ( | ||||
Settlement loss(2) | ( | ||||
Reclassification before tax | ( | ( | |||
Tax provision/(benefit) | ( | ||||
Total reclassification from accumulated other comprehensive (loss)/ income | $( | $ | $( | ||
Share Options | Weighted Average Exercise Price (Per Share) | Weighted Average Remaining Contractual Term | Aggregate Intrinsic Value (in millions) | ||||
Options outstanding as of December 31, 2024 | $ | ||||||
Granted | |||||||
Exercised | ( | ||||||
Forfeited | ( | ||||||
Options outstanding as of December 31, 2025 | $ | $ | |||||
Options exercisable as of December 31, 2025 | $ | $ |
2025 | 2024 | 2023 | |||
Expected volatility | |||||
Expected dividend yield | |||||
Expected forfeiture rate | |||||
Expected term of option | |||||
Risk-free rate of return |
Year Ended December 31, 2025 | Year Ended December 31, 2024 | Year Ended December 31, 2023 | |||
Intrinsic value of options exercised | $ | $ | $ | ||
Compensation expense recognized | $ | $ | $ | ||
Income tax benefit | $ | $ | $ |
Restricted Units | Weighted Average Price | ||
Non-vested as of December 31, 2024 | $ | ||
Granted | |||
Vested | |||
Forfeited | ( | ||
Non-vested as of December 31, 2025 | $ |
(in thousands, except per share amounts) | For the Year Ended December 31, | ||||
2025 | 2024 | 2023 | |||
Numerator | |||||
Income available to common stockholders (basic and diluted) | $ | $ | $ | ||
Denominator | |||||
Weighted-average number of common shares outstanding | |||||
Weighted-average number of warrants outstanding | |||||
Basic — weighted average number of shares outstanding | |||||
Effect of dilutive securities - time-vested options | |||||
Effect of dilutive securities - performance-based options | |||||
Effect of dilutive securities - restricted stock units | |||||
Diluted — weighted average number of shares outstanding | |||||
Earnings per share | |||||
Basic | $ | $ | $ | ||
Diluted | $ | $ | $ | ||
For the Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
Time vesting options | |||||
Performance vesting options | |||||
Year Ended December 31, 2025 | Year Ended December 31, 2024 | Year Ended December 31, 2023 | |||||||||||||||
(in thousands) | North America | International | Total | North America | International | Total | North America | International | Total | ||||||||
Net revenues | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||
Cost of sales(1) | |||||||||||||||||
Other segment items(2) | |||||||||||||||||
Adjusted EBITDA | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||
Reconciling items: | |||||||||||||||||
Interest expense, net | ( | ( | ( | ||||||||||||||
Depreciation and amortization | ( | ( | ( | ||||||||||||||
Refinancing and debt related costs | ( | ( | |||||||||||||||
Foreign exchange (loss)/gain on intercompany loans | ( | ( | |||||||||||||||
Share-based compensation | ( | ( | ( | ||||||||||||||
Strategic transaction costs | ( | ( | ( | ||||||||||||||
Pension termination costs | ( | ||||||||||||||||
Corporate and other | ( | ( | ( | ||||||||||||||
Income before taxes | $ | $ | $ | ||||||||||||||
For the Year Ended December 31, | |||||
(in thousands) | 2025 | 2024 | 2023 | ||
Net revenues: | |||||
United States | $ | $ | $ | ||
Czech Republic | |||||
Thailand | |||||
All other countries | |||||
Net revenues | $ | $ | $ | ||
For the Year Ended December 31, | |||
(in thousands) | 2025 | 2024 | |
Long-lived assets: | |||
United States | $ | $ | |
Czech Republic | |||
Thailand | |||
All other countries | |||
Total long-lived assets | $ | $ | |
(in thousands) | Supplier Financing Obligations |
Obligations outstanding at December 31, 2023 | $ |
New obligations | |
Payments against supplier obligations | ( |
Obligations outstanding at December 31, 2024 | |
New obligations | |
Payments against supplier obligations | ( |
Obligations outstanding at December 31, 2025 | $ |
Balance at Beginning of Period | Charges to Expense | Deductions | Impact of Foreign Exchange Rates | Balance at End of Period | |||||
December 31, 2025 | $ | ( | $ | ||||||
December 31, 2024 | $ | $ | |||||||
December 31, 2023 | $ | ( | $ |
Balance at Beginning of Period | Charges (Credits) to Expense | Deductions | Balance at End of Period | ||||
December 31, 2025 | $ | ( | $ | ||||
December 31, 2024 | $ | ( | $ | ||||
December 31, 2023 | $ | $ |
Exhibit Number | Description | |
3.1 | ||
3.2 | ||
4.1* | ||
10.1 | ||
10.2 | ||
10.3 | ||
10.4 | ||
10.5 | ||
10.6 | ||
10.7 |
10.8 | ||
10.9 | ||
10.10 | ||
10.11 | ||
10.12 | ||
10.13 | ||
10.14 | ||
10.15* | ||
10.16 | ||
10.17 | ||
10.18 | ||
10.19† | ||
10.20† | ||
10.21† |
10.22† | ||
10.23† | ||
10.24† | ||
10.25† | ||
10.26† | ||
10.27† | ||
10.28† | ||
10.29† | ||
10.30† | ||
10.31† | ||
10.32† | ||
10.33† | ||
10.34† | ||
10.35† | ||
10.36† | ||
19.1* | ||
21.1* | ||
23.1* | ||
31.1* | ||
31.2* | ||
32.1* | ||
32.2* | ||
97.1* | ||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. |
101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
Alliance Laundry Holdings Inc. | ||
By: | /s/ Michael D. Schoeb | |
Name: | Michael D. Schoeb | |
Title: | Chief Executive Officer and Director | |
Signature | Title | Date | |||
By: | /s/ Michael D. Schoeb | Chief Executive Officer and Director | |||
Michael D. Schoeb | (Principal Executive Officer) | March 13, 2026 | |||
By: | /s/ Dean Nolden | Chief Financial Officer | |||
Dean Nolden | (Principal Financial Officer) | March 13, 2026 | |||
By: | /s/ Brian Sikora | Chief Accounting Officer | |||
Brian Sikora | (Principal Accounting Officer) | March 13, 2026 | |||
By: | /s/ Clyde B. Anderson | ||||
Clyde B. Anderson | Director | March 13, 2026 | |||
By: | /s/ Timothy J. FitzGerald | ||||
Timothy J. FitzGerald | Director | March 13, 2026 | |||
By: | /s/ Phyllis A. Knight | ||||
Phyllis A. Knight | Director | March 13, 2026 | |||
By: | /s/ Narasimha Nayak | ||||
Narasimha Nayak | Director | March 13, 2026 | |||
By: | /s/ Robert L. Verigan | ||||
Robert L. Verigan | Director | March 13, 2026 | |||
By: | /s/ Amanda Hodges | ||||
Amanda Hodges | Director | March 13, 2026 | |||